ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: AMY ABERNETHY Was Named Chair of a New CancerLinQ Advisory Committee Within the Institute for Quality, An Affiliate Of The American Society of Clinical Oncology.

November 22, 2013

NCAB To Seek Changes In Cancer Act Renewal, Budget Improvements

November 20, 1987

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

Improved Prediction Of Cancer To Increase Pressure On Prevention, Greenwald Says

August 15, 1986

Chemo Can Harm Liver, Affect Surgical Outcomes

May 26, 2006

NIH appoints panel to review conflict of interest rules.

February 27, 2004